Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamnestic response to HBVAXPRO challenge in children previously vaccinated with HEXAVAC or INFANRIX-HEXA
2013-001602-28Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C.
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Recombivax HB in hepatitis B (HBV) (2 arms), sponsored by Sanofi Pasteur MSD S.N.C. Started May 2013; status: completed.
02
Drugs
Recombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2013-001602-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001602-28.